- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.12.25 | IMPEDIMED LIMITED: Application for quotation of securities - IPD | 1 | ASX | ||
| 03.12.25 | IMPEDIMED LIMITED: Positive Momentum in US Reimbursement Coverage Continues | - | ASX | ||
| 24.11.25 | IMPEDIMED LIMITED: Receipt of R&D tax incentive refund | - | ASX | ||
| 18.11.25 | IMPEDIMED LIMITED: AGM - Results of Meeting | - | ASX | ||
| IMPEDIMED Aktie jetzt für 0€ handeln | |||||
| 18.11.25 | IMPEDIMED LIMITED: AGM - CEO's Presentation | 2 | ASX | ||
| 18.11.25 | IMPEDIMED LIMITED: AGM - Chair's Address | 5 | ASX | ||
| 06.11.25 | IMPEDIMED LIMITED: Change of Director's Interest Notice - Ms Emmanuel-Donnelly | - | ASX | ||
| 06.11.25 | IMPEDIMED LIMITED: Change of Director's Interest Notice - Mr Andrew Grant | - | ASX | ||
| 06.11.25 | IMPEDIMED LIMITED: Change of Director's Interest Notice - Ms Janelle Delaney | - | ASX | ||
| 06.11.25 | IMPEDIMED LIMITED: Change of Director's Interest Notice - Ms Fiona Bones | - | ASX | ||
| 05.11.25 | IMPEDIMED LIMITED: Application for quotation of securities - IPD | - | ASX | ||
| 05.11.25 | IMPEDIMED LIMITED: Application for quotation of securities - IPD | - | ASX | ||
| 24.10.25 | IMPEDIMED LIMITED: Q1 FY26 results webinar & launch of Impedimed Investor Hub | - | ASX | ||
| 23.10.25 | IMPEDIMED LIMITED: Notification regarding FY26 Non-executive Director fees | - | ASX | ||
| 21.10.25 | IMPEDIMED LIMITED: Investor Presentation - Canaccord Drug and Device Conference | - | ASX | ||
| 16.10.25 | IMPEDIMED LIMITED: Online Meeting Guide | - | ASX | ||
| 16.10.25 | IMPEDIMED LIMITED: Notice of Annual General Meeting & Voting Form | - | ASX | ||
| 13.10.25 | IMPEDIMED LIMITED: Notification of cessation of securities - IPD | - | ASX | ||
| 13.10.25 | IMPEDIMED LIMITED: Notification regarding unquoted securities - IPD | - | ASX | ||
| 02.10.25 | IMPEDIMED LIMITED: Major US health insurer publishes positive coverage | - | ASX |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,140 | -1,74 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,170 | -1,45 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,730 | -2,55 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,400 | +2,54 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 132,30 | +1,72 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,740 | +0,23 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,225 | +2,41 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 30,760 | -2,22 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BETA BIONICS | 29,250 | -4,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 39,620 | -0,95 % | Carl Zeiss Meditec: JETZT LESEN! | ||
| ADAPTHEALTH | 9,670 | -2,81 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| PRIVIA HEALTH GROUP | 23,460 | -1,05 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| HEARTFLOW | 29,040 | -0,38 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| BILLIONTOONE | 89,29 | +9,10 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,090 | -0,98 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen |
IMPEDIMED LIMITED gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,018 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMPEDIMED LIMITED finden Sie auf Wallstreet Online.